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Pancreatic beta cells have well-developed ER to accommodate for the massive production and
secretion of insulin. ER homeostasis is vital for normal beta cell function. Perturbation of
ER homeostasis contributes to beta cell dysfunction in both type 1 and type 2 diabetes. To
systematically identify the molecular machinery responsible for proinsulin biogenesis and
maintenance of beta cell ER homeostasis, a widely used mouse pancreatic beta cell line, MIN6
cell was used to purify rough ER. Two different purification schemes were utilized. In each
experiment, the ER pellets were solubilized and analyzed by 1D SDS-PAGE coupled with
HPLC-MS/MS. A total of 1467 proteins were identified in three experiments with 95% con-
fidence, among which 1117 proteins were found in at least two separate experiments and
737 proteins found in all three experiments. GO analysis revealed a comprehensive profile of
known and novel players responsible for proinsulin biogenesis and ER homeostasis. Further
bioinformatics analysis also identified potential beta cell specific ER proteins as well as ER
proteins present in the risk genetic loci of type 2 diabetes. This dataset defines a molecular
environment in the ER for proinsulin synthesis, folding and export and laid a solid foun-
dation for further characterizations of altered ER homeostasis under diabetes-causing condi-
tions. All MS data have been deposited in the ProteomeXchange with identifier PXD001081
(http://proteomecentral.proteomexchange.org/dataset/PXD001081).
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In pancreatic beta cells, the well-developed ER is responsible
for the synthesis, folding, and export of proinsulin [1, 2].
Therefore, ER homeostasis, the balance between the client
protein load and processing capacity of the ER, is vital for
normal beta cell function. The disruption of ER homeostasis
contributes to beta cell dysfunction and death in both type 1
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and type 2 diabetes together affecting an estimated 285
million people worldwide [3–5]. Organellar proteomics rep-
resents an analytical strategy that combines biochemical frac-
tionation and comprehensive protein identification [6]. The
isolation of subcellular organelles leads to the reduced sample
complexity and links proteomics data to functional analysis
[7]. Because of its central role in the secretory pathway, the ER
has been the subject of a number of organellar proteomics
studies predominantly in liver and exocrine pancreas [8,9]. In
spite of the essential role of ER in normal proinsulin biogene-
sis and pathogenesis of diabetes, its protein composition has
not been systemically analyzed. In this study, we conducted
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a comprehensive proteomic analysis of the ER isolated from
MIN6 cells, a widely used mouse pancreatic beta cell line.
MIN6 cells were cultured at 37C with 5% CO2 in
DMEM containing 10% FBS, antibiotics, and 50 M
-mecaptoethanol. Two separate approaches were used to
isolate rough ER (rER). The first approach used differential
ultracentrifugation modified from previously described
methods [10,11]. Briefly, confluent MIN6 cells were homoge-
nized in a glass-Teflonmotor-driven homogenizer at 900 rpm
for ten strokes. After removing the cell debris, nuclei, and
mitochondria, the supernatant was centrifuged at 50 000 ×
g for 30 min at 4C to obtain the high density microsome
(HDM) fraction that containsmost of the rER. The second ap-
proach used a step sucrose gradient as previously published
by us [12]. Briefly, the homogenate was first centrifuged at
12 000 × g for 15 min at 4C to remove all cell debris, nuclei,
and mitochondria. The rER fraction was collected at the
1.35–2 M sucrose interface. In both approaches, ribosomes
were stripped off the rER using 1mM puromycin. Highly en-
riched ER was obtained with minimal contaminations from
cytosol or other organelles such asmitochondria and Golgi as
demonstrated by the Western blotting analysis using specific
organellar markers for the differential ultracentrifugation
approach (Fig. 1A) as well as for the step sucrose gradient
approach (data not shown) that is consistent with previously
published in exocrine pancreas ER [12].
The rER proteins were separated on 4–12% 1D SDS-
PAGE and stained with GelCode Blue stain reagent. Then
the entire lane was excised in 35 gel slices (Fig. 1B). In-
gel tryptic digestion was performed as previously published
[13–15]. The resulting peptides were separated on a reversed-
phase C18 column with a 90 min gradient using the Dionex
Ultimate HPLC system at a flow rate of 150 nL/min. MS and
MS/MS spectra were acquired on an Applied Biosystems QS-
TAR XL mass analyzer using information-dependent acqui-
sition mode. A MS scan was performed from m/z 400–1500
followed by product ion scans on two most intense multi-
ply charged ions. The peaklists were submitted to the Mas-
cot server to search against the UniProt database for Mus
musculus with carbamidomethyl (C) as a fixed modification
and oxidation (M), N-acetylation (protein N terminus) as vari-
able modifications, 0 or 1 missed tryptic cleavage, 100 ppm
mass tolerance for precursor ions and 0.6 Da for the fragment
ions. TheMascot search files were imported to Scaffold v3.4.3
and a self-BLAST procedure was performed to further reduce
protein redundancy.
Three separate rER preparations were analyzed by
GeLC-MS/MS, two biological replicate experiments (HDM1
and HDM2) using differential ultracentrifugation and one
experiment using step sucrose gradient (rER). The numbers
of unique proteins identified in each experiment is shown in
Fig. 1C. All together, 1467 unique proteins were identified
in all three experiments, among which 737 proteins were
found in all experiments and 1117 proteins in at least two
experiments. After removing keratin proteins, we annotated
the 725 proteins common to all three experiments (Support-
Figure 1. Purification and GeLC-MS/MS analysis of rER in MIN6
cells. (A) MIN6 cells were homogenized (total) and after clearing
cell debris, nucleus and mitochondria at 14 000g (P1), the high
density microsomes fractions containing the rER were collected
by ultracentrifugation (ER). The lighter fraction containing the low
density microsomes was also collected with an additional higher
speed spin (Golgi). Same amount of proteins were loaded for
WB to test for the ER markers: PDI, BiP, and Sec16L; the mito-
chondria marker: Cox4; the Golgi marker: Golgin97; the cytosolic
marker: beta-actin. (B) In three separate experiments using two
different purification schemes, 40 g of solubilized ER proteins
were separated in each lane. Thirty five gel slices were excised
from each lane for in-gel tryptic digestion. HDM1 and HDM2 were
replicate experiments using differential ultracentrifugation purifi-
cation and rER was the experiment using a step sucrose gradient.
(C) The numbers of unique proteins identified in three separate
experiments are shown in a Venn diagram. In three separate ex-
periments, 965, 1251, and 1105 unique proteins were identified
with >95% confidence in HDM1, HDM2, and rER experiments,
respectively.
ing Information Table 1). For their subcellular localizations
(Fig. 2A), the identified proteins included ER resident
proteins (29%) and proteins closely associated with ER
functions. A small portion of these proteins were likely
from contaminating organelles such as mitochondria (6%)
and nucleus (2%). Because a wide variety of secretory
proteins, so-called cargo proteins, transit through the ER, it is
anticipated that these cargo proteins account for a significant
portion of the rER proteome. These included secreted pro-
teins (secretory cargo, 5%), lysosomal proteins (3%), Golgi
proteins (2%), insulin secretory granule (ISG) proteins (2%)
as well as other membrane cargo (22%) with multiple or un-
specified subcellular destinations. Other identified proteins
also included the cytosolic proteins (12%) and cytoskeleton
proteins (4%). Although these proteins are not processed
through the ER, many of them play very important roles in
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Figure 2. Classification of the identified
proteins from purified rER in MIN6 cells.
(A) Subcellular localization of proteins
identified in all three experiments were
analyzed and presented as percentage
of the total 725 proteins. (B) Six hun-
dred seventy identified rER and associ-
ated proteins were classified in 13 func-
tional categories. The percentage of to-
tal proteins in each category is illustrated
in the pie chart. In both charts, the cat-
egories are sorted from the highest per-
centage to the lowest percentage.
the ER functions. These proteins included the COPI and
COPII coat proteins, required for retrograde and anterograde
ER to Golgi transport, respectively, as well as key members of
BAG family for the posttranslational delivery of tail-anchored
membrane proteins to the ER. After excluding the contam-
inating mitochondrial and nucleus proteins, the remaining
670 proteins were further clustered into functional categories
(Fig. 2B). The ER resident and associated proteins fall in
several functional categories including protein translation
and translocation (13%), protein folding/chaperones (6%),
oxidoreductase (4%), ER-associated degradation (ERAD)
(3%), ER export (7%), membrane trafficking (18%), lipid
metabolism (7%), and glycosylation (3%). In addition, a
group of proteins in the “Unknown” category (9%) do not
have functional information available in the public database
or literatures. In an attempt to look for potential beta cell spe-
cific/upregulated ER proteins, we compared, by automatic
BLAST and then manual confirmations, the current ER pro-
tein list with previously published ER proteins that we have
compiled and published previously [8]. The results are listed
in the column I and J of the Supporting Information Table.
The ER proteins most relevant to proinsulin folding in-
cluded the heat shock proteins from Hsp40, Hsp70, and
Hsp90 families, protein disulfide-isomerases A1, A3-A6, BiP,
oxidoreductases Ero1a, and Ero1b that is known to be highly
enriched in beta cells, Erp29, Erp44, and Erp46, DnaJ ho-
mologs including Dnajc3 (also called p58IPK), Torsin 1–3
and Toll-like receptor-specific cochaperone Cnpy2,3,4. In the
ER export category, a large number of proteins involved in
ER to Golgi transport have been identified including COPII
coat proteins Sec31a, Sec13, Sec24a, Sar1b, and its gua-
nine nucleotide exchange factor mSec12; known or potential
cargo receptors such as Lman1, Lman2, p24 familymembers,
Surf4, and Bap31; and most interestingly, two recently dis-
covered COPII cargo adaptors, Mia3 (also called TANGO1)
and cTAGE5 required for procollagen secretion primarily in
chondrocytes and fibroblasts [16,17]. However, their potential
roles in beta cell secretion are unknown. In addition to the
ER chaperones and export proteins, several identified beta
cell ER proteins have been associated with type 2 diabetes in
the genome-wide association studies [18,19]. These included
WFS1, ZnT8 (as a transient cargo), and CDKAL1, among
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which CDKAL1 was very recently found to be a novel tail-
anchored ER protein in beta cells [20]. Additional ER proteins
also found as risk loci of type 2 diabetes are listed in the
Supporting Information Table. Among these proteins, three
proteins, CDKAL1, ZnT8, and TM163 are of the most inter-
est because they are present in the T2D risk loci as well as
being the potential beta cell-specific ERproteins. Other poten-
tial beta cell-specific ER proteins, from our BLAST analysis,
revealed an upregulation of machineries involved in proin-
sulin biogenesis, including the neuroendocrine convertases,
protein disulfide isomerases as well as serveral proteins reg-
ulating unfolded protein response.
In this study, we compared two different approaches to
isolate rER from a pancreatic beta cell line, MIN6 cells. We
found both methods yielded highly enriched rER fractions
and identified similar numbers of proteins. Either method
can be used in future studies to characterize the alteration
of ER homeostasis under diabetes-causing conditions. A
fairly detailed molecular model starts to emerge from this
comprehensive profiling that includes potential key players
regulating proinsulin folding, degradation, and ER export.
The specific roles of these players at each step of proinsulin
processing and ER homeostasis will be gradually unveiled
in subsequent quantitative proteomic and functional studies
to perturb beta cell ER homeostasis using combined genetic
and biochemical approaches.
TheMS proteomics data have been deposited to the ProteomeX-
changeConsortium [21] via the PRIDEpartner repository with the
dataset identifier PXD001081 and DOI 10.6019/PXD001081
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